Quest Diagnostics Incorporated
Quest Diagnostics provides diagnostic testing and services internationally. They offer routine, non-routine, and advanced clinical testing, anatomic pathology testing, and other diagnostic services. Services are provided under various brands to physicians, hospitals, patients, and others. The company also offers risk assessment services for the life insurance industry and IT solutions for healthcare organizations.
Overview
Strengths
- Shows the financial signature of a durable competitive advantage (economic moat): returns well above its cost of capital, an asset-light, cash-generative model and operating margins that held up every year.
- Creates economic value: ROIC of 14.5% against a cost of capital (WACC) of 6.6%, a spread of 7.9 percentage points.
- Asset-light, cash-generative model: capital expenditure takes only 4.3% of revenue and free cash flow was positive in each of the last 6 years.
- Resilient profitability: operating margin stayed between 14% and 22% in each of the last 6 years.
- Improving fundamentals over the last year: return on assets up 0.7 points and asset turnover up 11.3%.
Weaknesses
- Our discounted cash flow target price (150.84 USD) is 41% below the current price.
- More expensive than its own history: P/E 28.3x vs. a historical average of 15.5x, P/FCF 20.7x vs. a historical average of 13.6x and EV/EBITDA 15.5x vs. a historical average of 9.9x.
Key Financial Data